David T. Melnekoff
- Structural Biology top 2%
- Hematology top 10%
- Multiple Myeloma Research and Treatments 19
-
- Protein Degradation and Inhibitors 9
- vaccines and immunoinformatics approaches 1
-
- CAR-T cell therapy research 4
-
- Immunotherapy and Immune Responses 3
-
- Chronic Lymphocytic Leukemia Research 2
-
- Cancer Genomics and Diagnostics 2
-
- Monoclonal and Polyclonal Antibodies Research 2
- Co-authors
- Alessandro LaganàSamir ParekhSundar JagannathVioletta V. LeshchenkoJoel T. DudleyAjai ChariZhening ZhangIvan Razinkov
- Partner nations
- United StatesIndia
In The Last Decade
David T. Melnekoff
22 papers receiving 347 citations
Peers
Comparison fields: 5 of 75
- Structural Biology 75
- Hematology 118
- Surfaces, Coatings and Films 35
- Molecular Biology 205
- Oncology 81
Countries citing papers authored by David T. Melnekoff
This map shows the geographic impact of David T. Melnekoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David T. Melnekoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David T. Melnekoff more than expected).
Fields of papers citing papers by David T. Melnekoff
This network shows the impact of papers produced by David T. Melnekoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David T. Melnekoff. The network helps show where David T. Melnekoff may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David T. Melnekoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2022 | 14 | |
| 3 | 2022 | 15 | |
| 4 | 2022 | 4 | |
| 5 | 2021 | 7 | |
| 6 | 2021 | 2 | |
| 7 | 2021 | 7 | |
| 8 | 2021 | 2 | |
| 9 | 2021 | 56 | |
| 10 | 2021 | 1 | |
| 11 | 2019 | 59 | |
| 12 | 2019 | 3 | |
| 13 | 2018 | 3 | |
| 14 | 2018 | 8 | |
| 15 | 2018 | 22 | |
| 16 | 2017 | 2 | |
| 17 | 2017 | 2 | |
| 18 | 2017 | 43 | |
| 19 | 2016 | 95 | |
| 20 | 2016 | 1 |
About David T. Melnekoff
David T. Melnekoff is a scholar working on Hematology, Structural Biology and Genetics, having authored 22 papers that have together received 350 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (19 papers), Protein Degradation and Inhibitors (9 papers), CAR-T cell therapy research (4 papers), Immunotherapy and Immune Responses (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Cancer Genomics and Diagnostics (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and vaccines and immunoinformatics approaches (1 paper). The work is most often cited by research in Structural Biology (75 citations), Hematology (118 citations) and Surfaces, Coatings and Films (35 citations). David T. Melnekoff has collaborated with scholars based in United States and India. Frequent co-authors include Alessandro Laganà, Samir Parekh, Sundar Jagannath, Violetta V. Leshchenko, Joel T. Dudley, Ajai Chari, Zhening Zhang, Ivan Razinkov, Hui Wei and William J. Rice. Their work appears in journals such as Blood, Clinical Cancer Research and Science Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.